JP Stock MarketDetailed Quotes

7096 StemCell Institute

Watchlist
  • 1289
  • -27-2.05%
20min DelayMarket Closed Dec 30 15:30 JST
13.21BMarket Cap42.47P/E (Static)

StemCell Institute Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

StemCell Institute Q2 2025 Earnings Date

Currency：JPYNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
722.00M
695.00M
-27.00M
Miss Est.
--
+9.20%
-3.74%
EPS
--
9.13
--
+11.34%
Analyst Rating
No Data

StemCell Institute Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 770.000M--
Feb 13, 20252025/Q3-- / 757.000M--
Nov 12, 20242025/Q2695.000M / 722.000M--
Aug 7, 20242025/Q1678.000M / 700.000M--
May 14, 20242024/Q4597.000M / 686.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 770.000M--
Feb 13, 20252025/Q3-- / 757.000M--
Nov 12, 20242025/Q2695.000M / 722.000M--
Aug 7, 20242025/Q1678.000M / 700.000M--
May 14, 20242024/Q4597.000M / 686.000M--

Unlock Free Earnings Estimates

StemCell Institute Earnings Reports

  • StemCell Institute: Confirmation letter

    Nov 14, 2024 01:33 ET

  • StemCell Institute: Half Year Report - Term 26 (2024/04/01 - 2025/03/31)

    Nov 14, 2024 01:31 ET

  • StemCell Institute: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)

    Nov 12, 2024 01:30 ET

  • StemCell Institute: Financial results briefing materials for the 2nd quarter (interim period) of the fiscal year ending March 31, 2025

    Nov 12, 2024 01:30 ET

    • Read more

    Heat List
    JP
    Overall
    Symbol
    Price
    % Chg

    No Data